809 related articles for article (PubMed ID: 23516360)
1. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.
Sáez-Cirión A; Bacchus C; Hocqueloux L; Avettand-Fenoel V; Girault I; Lecuroux C; Potard V; Versmisse P; Melard A; Prazuck T; Descours B; Guergnon J; Viard JP; Boufassa F; Lambotte O; Goujard C; Meyer L; Costagliola D; Venet A; Pancino G; Autran B; Rouzioux C;
PLoS Pathog; 2013 Mar; 9(3):e1003211. PubMed ID: 23516360
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.
Noel N; Peña R; David A; Avettand-Fenoel V; Erkizia I; Jimenez E; Lecuroux C; Rouzioux C; Boufassa F; Pancino G; Venet A; Van Lint C; Martinez-Picado J; Lambotte O; Sáez-Cirión A; Prado JG
J Virol; 2016 Jul; 90(13):6148-6158. PubMed ID: 27122576
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
Frange P; Faye A; Avettand-Fenoël V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; Sáez-Cirión A;
Lancet HIV; 2016 Jan; 3(1):e49-54. PubMed ID: 26762993
[TBL] [Abstract][Full Text] [Related]
7. Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
Chereau F; Madec Y; Sabin C; Obel N; Ruiz-Mateos E; Chrysos G; Fidler S; Lehmann C; Zangerle R; Wittkop L; Reiss P; Hamouda O; Estrada Perez V; Leal M; Mocroft A; Garcia De Olalla P; Ammassari A; D'Arminio Monforte A; Mussini C; Segura F; Castagna A; Cavassini M; Grabar S; Morlat P; De Wit S; Lambotte O; Meyer L;
PLoS One; 2017; 12(4):e0173893. PubMed ID: 28380038
[TBL] [Abstract][Full Text] [Related]
8. A case report of HIV-1 superinfection in an HIV controller leading to loss of viremia control: a retrospective of 10 years of follow-up.
Caetano DG; Côrtes FH; Bello G; de Azevedo SSD; Hoagland B; Villela LM; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
BMC Infect Dis; 2019 Jul; 19(1):588. PubMed ID: 31277590
[TBL] [Abstract][Full Text] [Related]
9. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
Buzon MJ; Martin-Gayo E; Pereyra F; Ouyang Z; Sun H; Li JZ; Piovoso M; Shaw A; Dalmau J; Zangger N; Martinez-Picado J; Zurakowski R; Yu XG; Telenti A; Walker BD; Rosenberg ES; Lichterfeld M
J Virol; 2014 Sep; 88(17):10056-65. PubMed ID: 24965451
[TBL] [Abstract][Full Text] [Related]
10. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.
Trémeaux P; Lemoine F; Mélard A; Gousset M; Boufassa F; Orr S; Monceaux V; Gascuel O; Lambotte O; Hocqueloux L; Saez-Cirion A; Rouzioux C; Avettand-Fenoel V
Microbiol Spectr; 2023 Feb; 11(1):e0326722. PubMed ID: 36692300
[TBL] [Abstract][Full Text] [Related]
11. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
12. Post-treatment controllers after treatment interruption in chronically HIV-infected patients.
Maggiolo F; Di Filippo E; Comi L; Callegaro A
AIDS; 2018 Mar; 32(5):623-628. PubMed ID: 29334553
[TBL] [Abstract][Full Text] [Related]
13. HIV post-treatment controllers have distinct immunological and virological features.
Etemad B; Sun X; Li Y; Melberg M; Moisi D; Gottlieb R; Ahmed H; Aga E; Bosch RJ; Acosta EP; Yuki Y; Martin MP; Carrington M; Gandhi RT; Jacobson JM; Volberding P; Connick E; Mitsuyasu R; Frank I; Saag M; Eron JJ; Skiest D; Margolis DM; Havlir D; Schooley RT; Lederman MM; Yu XG; Li JZ
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2218960120. PubMed ID: 36877848
[TBL] [Abstract][Full Text] [Related]
14. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
15. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties.
Vigano S; Negron J; Ouyang Z; Rosenberg ES; Walker BD; Lichterfeld M; Yu XG
J Virol; 2015 Aug; 89(15):7829-40. PubMed ID: 25995260
[TBL] [Abstract][Full Text] [Related]
16. Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
Van Gulck E; Bracke L; Heyndrickx L; Coppens S; Atkinson D; Merlin C; Pasternak A; Florence E; Vanham G
PLoS One; 2012; 7(5):e37792. PubMed ID: 22666392
[TBL] [Abstract][Full Text] [Related]
17. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
18. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir.
Calin R; Hamimi C; Lambert-Niclot S; Carcelain G; Bellet J; Assoumou L; Tubiana R; Calvez V; Dudoit Y; Costagliola D; Autran B; Katlama C;
AIDS; 2016 Mar; 30(5):761-9. PubMed ID: 26730568
[TBL] [Abstract][Full Text] [Related]
19. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
Rozera G; Abbate I; D'Offizi G; Corpolongo A; Narciso P; Vlassi C; Martini F; Calcaterra S; Capobianchi MR
J Med Virol; 2007 Aug; 79(8):1047-54. PubMed ID: 17597482
[TBL] [Abstract][Full Text] [Related]
20. Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study.
Goujard C; Marcellin F; Hendel-Chavez H; Burgard M; Meiffrédy V; Venet A; Rouzioux C; Taoufik Y; El Habib R; Beumont-Mauviel M; Aboulker JP; Lévy Y; Delfraissy JF;
AIDS Res Hum Retroviruses; 2007 Sep; 23(9):1105-13. PubMed ID: 17919105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
